Prediction of breast cancer prognosis using gene set statistics provides signature stability and biological context

BMC Bioinformatics

Volumn 11, Issue , 2010, Pages

  Abraham, Gad ^a   Kowalczyk, Adam ^a   Loi, Sherene ^b,c   Haviv, Izhak ^a,c,d   Zobel, Justin ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b JULES BORDET INSTITUTE   (Belgium)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

^d BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PATHWAYS; BOOTSTRAP REPLICATIONS; BREAST CANCER; BREAST CANCER PROGNOSIS; EXPRESSION LEVELS; GENE EXPRESSION DATA; GENE LISTS; PREDICTING OUTCOMES;

DIAGNOSIS; DISEASES;

GENE EXPRESSION;

TUMOR MARKER;

ARTICLE; BREAST TUMOR; FEMALE; GENE EXPRESSION PROFILING; GENETICS; HUMAN; METHODOLOGY; PROGNOSIS;

BREAST NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 77952478860     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/1471-2105-11-277     Document Type: Article

References (58)

1. van't Veer LJ, Dai H, Vijver MJ, He YD, Hart AAM, Mao M, Peterse HL, Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH. Gene expression profiling predicted clinical outcome of breast cancer. Nature 2002, 415:530-536. 10.1038/415530a, 11823860.
2. Vijver MJ, He YD, van 't Veer LJ, Dai H, Hart AAM, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, Velde T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R. A gene-expression signature as a predictor of survival in breast cancer. New Engl J Med 2002, 347:1999-2009. 10.1056/NEJMoa021967, 12490681.
3. Ein-Dor L, Kela I, Getz G, Givol D, Domany E. Outcome signature genes in breast cancer: is there a unique set?. Bioinformatics 2005, 21:171-178. 10.1093/bioinformatics/bth469, 15308542.
4. Michiels S, Koscielny S, Hill C. Prediction of cancer outcome with microarrays: a multiple random validation study. The Lancet 2005, 365:488-492.
5. Fan C, Oh DS, Wessels L, Weigelt B, Nuyten DSA, Nobel AB, van't Veer LJ, Perou CM. Concordance among Gene-Expression-Based Predictors for Breast Cancer. N Engl J Med 2006, 355:560-569. 10.1056/NEJMoa052933, 16899776.
6. Reyal F, van Vliet MH, Armstrong NJ, Horlings HM, de Visser KE, Kok M, Teschendorff AE, Mook S, van 't Veer L, Caldas C, Salmon RJ, Vijver MJ, Wessels LFA. A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the Proliferation, Immune response and RNA splicing modules in breast cancer. Breast Cancer Res 2008, 10:R93. 10.1186/bcr2192, 2656909, 19014521.
7. Yu JX, Sieuwerts AM, Zhang Y, Martens JWM, Smid M, Klijn JGM, Wang Y, Foekens JA. Pathway analysis of gene signatures predicting metastasis of node-negative primary breast cancer. BMC Cancer 2007, 7:182. 10.1186/1471-2407-7-182, 2077336, 17894856.
8. Haibe-Kains B, Desmedt C, Sotiriou C, Bontempi G. A comparative study of survival models for breast cancer prognostication based on microrarray data: does a single gene beat them all?. Bioinformatics 2008, 24:2200-2208. 10.1093/bioinformatics/btn374, 2553442, 18635567.
9. Lai C, Reinders MJT, van't Veer LJ, Wessels LFA. A comparison of univariate and multivariate gene selection techniques for classification of cancer datasets. BMC Bioinfo 2006, 7:235.
10. Segal E, Shapira M, Regev A, Pe'er D, Botstein D, Koller D, Friedman N. Module networks: identifying regulatory modules and their condition-specific regulators from gene expression data. Nat Genet 2003, 34:166-176. 10.1038/ng1165, 12740579.
11. Yousef M, Jung S, Showe LC, Showe MK. Recursive Cluster Elimination (RCE) for classification and feature selection from gene expression data. BMC Bioinfo 2007, 8:article 144.
12. van Vliet MH, Klijn CN, Wessels LFA, Reinders MJT. Module-Based Outcome Prediction Using Breast Cancer Compendia. PLoS ONE 2007, 2. 10.1371/journal.pone.0001047, 2002511, 17940611.
13. Chuang HY, Lee E, Liu YT, Lee D, Ideker T. Network-based classification of breast cancer metastasis. Mol Sys Biol 2007, 3.
14. Svensson JP, Stalpers LJA, van Lange REEE, Franken NAP, Haveman J, Klein B, Turesson I, Vrieling H, Giphart-Gassler M. Analysis of Gene Expression Using Gene Sets Discriminates Cancer Patients with and without Late Radiation Toxicity. PLoS Medicine 2006, 3:e422. 10.1371/journal.pmed.0030422, 1626552, 17076557.
15. Ashburner M, Ball CA, Blake JA, Botstein D, an J M Cherry HB, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G. Gene Ontology: tool for the unification of biology. Nat Genet 2000, 25:25-29. 10.1038/75556, 10802651.
16. Kim SY, Kim YS. A gene sets approach for identifying prognostic gene signatures for outcome prediction. BMC Genomics 2008, 9.
17. Lee E, Chuang HY, Kim JW, Ideker T, Lee D. Inferring Pathway Activity toward Precise Disease Classification. PLoS Comput Biol 2008, 4. 2563693, 18989396.
18. Guo Z, Zhang T, Li X, Wang Q, Xu J, Yu H, Zhu J, Wang H, Wang C, Topol EJ, Wang Q, Rao S. Towards precise classification of cancers based on robust gene functional expression profiles. BMC Bioinfo 2005, 6:article 58.
19. Bild AH, Yao G, Chang JT, Wang Q, Potti, Chasse D, Joshi MB, Harpole D, Lancaster JM, Berchuck A, Olson JA, Marks JR, Dressman HK, West M, Nevins JR. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 2006, 439(7074):353-357. 10.1038/nature04296, 16273092.
20. Törönen P, Ojala PJ, Maartinen P, Holm L. Robust extraction of functional signals from gene set analysis using a generalized threshold free scoring function. BMC Bioinfo 2009, 10:307.
21. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci 2005, 102:15545-15550. 10.1073/pnas.0506580102, 1239896, 16199517.
22. Ackermann M, Strimmer K. A general modular framework for gene set enrichment analysis. BMC Bioinfo 2009, 10:47.
23. Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucl Acid Res 2002, 30:207-210.
24. Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, Yang F, Talantov D, Timmermans M, van Gelder MM, Yu J, Jatkoe T, Berns EM, Atkins D, Foekens JA. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. The Lancet 2005, 365:671-679.
25. Ivshina AV, George J, Senko O, Mow B, Putti TC, Smeds J, Lindahl T, Pawitan Y, Hall P, Nordgren H, Wong JE, Liu ET, Bergh J, Kuznetsov VA, Miller LD. Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. Cancer Res 2006, 66:10292-10301. 10.1158/0008-5472.CAN-05-4414, 17079448.
26. Loi S, Haibe-Kains B, Desmedt C, Lallemand F, Tutt AM, Gillet C, Ellis P, Harris A, Bergh J, Foekens JA, Klijn JGM, Larsimont D, Buyse M, Bontempi G, Delorenzi M, Piccart MJ, Sotiriou C. Definition of Clinically Distinct Molecular Subtypes in Estrogen Receptor-Positive Breast Carcinomas Through Genomic Grade. J Clin Oncol 2007, 25:1239-1246. 10.1200/JCO.2006.07.1522, 17401012.
27. Loi S, Haibe-Kains B, Desmedt C, Wirapati P, Lallemand F, Tutt AM, Gillet C, Ellis P, Ryder K, Reid JF, Daidone MG, Pierotti MA, Berns EM, Jansen MP, Foekens JA, Delorenzi M, Bontempi G, Piccart MJ, Sotiriou C. Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen. BMC Genomics 2008, 9. 10.1186/1471-2164-9-239, 2423197, 18498629.
28. Desmedt C, Piette F, Loi S, Wang Y, Lallemand F, Haibe-Kains B, Viale G, Delorenzi M, Zhang Y, d'Assignies MS, Bergh J, Lidereau R, Ellis P, Harris AL, Klijn JG, Foekens JA, Cardoso F, Piccart MJ, Buyse M, Sotiriou C, Consortium T. Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series. Clin Cancer Res 2007, 13:3207-3214. 10.1158/1078-0432.CCR-06-2765, 17545524.
29. Schmidt M, Böhm D, von Törne C, Steiner E, Puhl A, Pilch H, Lehr HA, Hengstler JG, Kölbl J, Gehrmann M. The Humoral Immune System Has a Key Prognostic Impact in Node-Negative Breast Cancer. Cancer Res 2008, 68:5405-5413. 10.1158/0008-5472.CAN-07-5206, 18593943.
30. Harrell FE. Regression Modeling Strategies 2001, Springer.
31. Kanehisa M, Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucl Acid Res 2000, 28:27-30.
32. Tian L, Greenberg SA, Kong SW, Altschuler J, Kohane IS, Park PJ. Discovering statistically significant pathways in expression profiling studies. Proc Natl Acad Sci 2005, 102:13544-13549. 10.1073/pnas.0506577102, 1200092, 16174746.
33. Efron B, Tibshirani R. On testing the significance of sets of genes. Annal Stat 2007, 1:107-129.
34. Park MY, Hastie T, Tibshirani R. Averaged gene expressions for regression. Biostatistics 2007, 8:212-227. 10.1093/biostatistics/kxl002, 16698769.
35. Lehmann EL. Nonparametrics. Statistical Methods Based on Ranks 1975, McGraw-Hill.
36. Goeman JJ, Bühlmann P. Analyzing gene expression data in terms of gene sets: methodological issues. Bioinformatics 2007, 23:980-987. 10.1093/bioinformatics/btm051, 17303618.
37. Barry WT, Nobel AB, Wright FA. A statistical framework for testing functional categories in microarray data. Ann Appl Stat 2008, 2:286-315.
38. Schölkopf B, Smola AJ. Learning with Kernels 2002, MIT Press.
39. Bedo J, Sanderson C, Kowalczyk A. An Efficient Alternative to SVM Based Recursive Feature Elimination with Applications in Natural Language Processing and Bioinformatics. Proc Aust Joint Conf AI 2006, Sattar A, Kang BH.
40. Tibshirani R, Hastie T, Narasimhan B, Chu G. Class Prediction by Nearest Shrunken Centroids, with Applications to DNA Microarrays. Stat Sci 2003, 18:104-117.
41. Dabney AR, Storey JD. Optimality driven nearest centroid classification from genomic data. PLoS One 2007, 2:e1002. 10.1371/journal.pone.0001002, 1991588, 17912341.
42. McLachlan GJ, Do KA, Ambroise C. Analyzing Microarray Gene Expression Data 2004, Wiley Interscience.
43. Varma S, Simon R. Bias in error estimation when using cross-validation for model selection. BMC Bioinfo 2006, 7.
44. Binder H, Schumacher M. Adapting Prediction Error Estimates for Biased Complexity Selection in High-Dimensional Bootstrap Samples. Statist Appl Genet Mol Biol 2008, 7.
45. Hastie T, Tibshirani R, Friedman J. The Elements of Statistical Learning 2001, Springer.
46. Downward J. Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer 2003, 3:11-22. 10.1038/nrc969, 12509763.
47. Dai H, van't Veer L, Lamb J, He YD, Mao M, Fine BM, Bernards R, Vijver M, Deutsch P, Sachs A, Stoughton R, Friend S. A cell proliferation signature is a marker of extremely poor outcome in a subpopulation of breast cancer patients. Cancer Res 2005, 65:4059-4066. 10.1158/0008-5472.CAN-04-3953, 15899795.
48. Mosley JD, Keri RA. Cell cycle correlated genes dictate the prognostic power of breast cancer gene lists. BMC Med Genom 2008, 1:11.
49. van Diest PJ, Wall E, Baak JPA. Prognostic value of proliferation in invasive breast cancer: a review. J Clin Pathol 2004, 57:675-681. 10.1136/jcp.2003.010777, 1770351, 15220356.
50. Sørlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S, Demeter J, Perou CM, Lønning PE, Brown PO, Børresen-Dale AL, Botstein D. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci 2003, 100:8418-8423. 10.1073/pnas.0932692100, 166244, 12829800.
51. Desmedt C, Haibe-Kains B, Wirapati P, Buyse M, Larsimont D, Bontempi G, Delorenzi M, Piccart M, Sotiriou C. Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes. Clin Cancer Res 2008, 14:5158-5165. 10.1158/1078-0432.CCR-07-4756, 18698033.
52. Buyse M, Loi S, van 't Veer L, Viale G, Delorenzi M, Glas AM, d'Assignies MS, Bergh J, Lidereau R, Ellis P, Harris A, Bogaerts J, Therasse P, Floore A, Amakrane M, Piette F, Rutgers E, Sotiriou C, Cardoso F, Piccart MJ, Consortium T. Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer. JNCI 2006, 98:1183-1192.
53. Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, Lickley LA, Rawlinson E, Sun P, Narod SA. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res 2007, 13:4429-4434. 10.1158/1078-0432.CCR-06-3045, 17671126.
54. Teschendorff AE, Naderi A, Barbosa-Morais NL, Pinder SE, Ellis IO, Aparicio S, Brenton JD, Caldas C. A consensus prognostic gene expression classifier for ER positive breast cancer. Genome Biol 2006, 7:R101. 10.1186/gb-2006-7-10-r101, 1794561, 17076897.
55. Goeman J. penalized. L1 (lasso) and L2 (ridge) penalized estimation in GLMs and in the Cox model 2008, [R package version 0.9-22]., http://www.msbi.nl/goeman
56. Karatzoglou A, Smola A, Hornik K, Zeileis A. kernlab - An S4 Package for Kernel Methods in R. Journal of Statistical Software 2004, 11(9):1-20., http://www.jstatsoft.org/v11/i09/
57. Morley M, Molony CM, Weber TM, Devlin JL, Ewens KG, Spielman RS, Cheung VG. Genetic analysis of genome-wide variation in human gene expression. Nature 2004, 430:743-747. 10.1038/nature02797, 15269782.
58. Brentani H, Caballero OL, Camargo AA, da Silva AM, da Silva WA, Neto ED, Grivet M, Gruber A, Guimaraes PEM, Hide W, Iseli C, Jongeneel CV, Kelso J, Nagai MA, Ojopi EPB, et al. The generation and utilization of a cancer-oriented representation of the human transcriptome by using expressed sequence tags. Proc Natl Acad Sci 2003, 100:13148-13423.